The Athlete's Foot

The Athlete's Foot
Name	The Athlete's Foot
Field	Dermatology, Infectious disease
Symptoms	Pruritus, erythema, scaling, fissures
Complications	Secondary bacterial infection, cellulitis, onychomycosis
Causes	Dermatophyte fungi (Trichophyton, Epidermophyton)
Risks	Occlusive footwear, communal showers, immunosuppression, diabetes mellitus
Diagnosis	Clinical examination, KOH preparation, fungal culture, PCR
Treatment	Topical azoles, allylamines, oral terbinafine, griseofulvin
Frequency	Common; global

The Athlete's Foot is a dermatophyte infection of the interdigital spaces and plantar surfaces of the foot primarily caused by species of Trichophyton and Epidermophyton. It presents with pruritic, scaly, erythematous lesions and can extend to toenails and hands, leading to onychomycosis and tinea manuum. Management involves topical or systemic antifungals, hygiene measures, and addressing risk factors such as occlusive footwear and communal facilities.

Introduction

Athlete's foot, clinically categorized under tinea pedis, is a superficial cutaneous mycosis influenced by host factors and environmental exposures linked to institutions such as Olympic Games, FIFA World Cup, NCAA, US Olympic Committee, English Football League, and military settings like United States Army barracks. Historical descriptions appear in dermatology texts alongside conditions studied at institutions including Mayo Clinic, Johns Hopkins Hospital, St Thomas' Hospital, Royal College of Physicians, and in reviews from journals such as The Lancet, The New England Journal of Medicine, British Medical Journal, and Annals of Internal Medicine. Epidemiologic surveys by agencies like the World Health Organization, Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, and national public health institutes report variable prevalence by climate and lifestyle.

Signs and symptoms

Common presentations include interdigital maceration, plantar scaling, vesiculobullous eruptions, and chronic hyperkeratotic plaques often misattributed in clinic settings overseen by specialists from American Academy of Dermatology, Canadian Dermatology Association, European Academy of Dermatology and Venereology, Royal Australasian College of Physicians, and dermatology departments at Harvard Medical School, Stanford University School of Medicine, University of Oxford, University of Cambridge, Karolinska Institutet. Symptoms recorded in case series published by investigators at Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Guy's and St Thomas' NHS Foundation Trust include intense pruritus, burning, fissuring, and secondary odor. Physical exam findings correlate with diagnostic tests used in labs such as Centers for Disease Control and Prevention reference mycology units and university mycology labs at University of California, San Francisco and University of Toronto.

Causes and transmission

Etiologic agents are dermatophytes in the genera Trichophyton, Epidermophyton, and occasionally Microsporum, with species like Trichophyton rubrum and Trichophyton interdigitale predominating in reports from World Health Organization surveillance and mycology surveys at National Institutes of Health funded centers. Transmission occurs via fomites in communal environments including public baths, swimming pools, military barracks, sports arenas, and facilities operated by organizations like YMCA, LA Fitness, Equinox, and other athletic clubs. Host susceptibility is linked to comorbidities managed by institutions such as American Diabetes Association and International Society of Nephrology, immunosuppression seen in patients under care at Memorial Sloan Kettering Cancer Center and transplant units like Mayo Clinic Transplant Center, and behavioral risk factors noted in cohorts from University of Sydney, University of Melbourne, and University of Cape Town.

Diagnosis

Diagnosis relies on clinical assessment supported by microscopy using potassium hydroxide prepared specimens and culture on Sabouraud dextrose agar in laboratories such as those at Centers for Disease Control and Prevention, Public Health England, Robert Koch Institute, and university mycology labs at Yale School of Medicine and Imperial College London. Molecular diagnostics including PCR assays validated by consortia affiliated with European Centre for Disease Prevention and Control and National Institutes of Health improve species identification. Differential diagnosis considered by clinicians from American Academy of Family Physicians, British Association of Dermatologists, and specialist clinics at Johns Hopkins Hospital include contact dermatitis, psoriasis, erythrasma (caused by Corynebacterium minutissimum), and cutaneous candidiasis managed in infectious disease units at Mayo Clinic.

Treatment and management

First-line therapy involves topical antifungals such as azoles and allylamines recommended in guidelines from American Academy of Dermatology, European Academy of Dermatology and Venereology, Royal College of General Practitioners, and state health departments; agents include topical terbinafine, clotrimazole, miconazole, and tolnaftate. Refractory or extensive disease may require oral antifungals like terbinafine, itraconazole, or griseofulvin prescribed in settings like Massachusetts General Hospital or Cleveland Clinic. Adjunctive measures include foot hygiene protocols promoted by World Health Organization guidance, drying agents, footwear modification supported by podiatry services at American Podiatric Medical Association, and treatment of coexistent onychomycosis via dermatology clinics at University of Pennsylvania Health System.

Prevention

Preventive strategies emphasized by public health campaigns at Centers for Disease Control and Prevention, World Health Organization, Public Health England, and local health departments include avoiding barefoot exposure in communal areas, using antifungal powders, rotating footwear, and maintaining foot hygiene advocated by American Podiatric Medical Association and sports medicine programs at Aspetar Orthopaedic and Sports Medicine Hospital, FIFA Medical Centre of Excellence, and university athletic departments such as University of Michigan Athletics.

Epidemiology

Prevalence varies by geography, climate, and population, with higher rates reported in tropical regions and among athletes, military personnel, and urban populations in studies from India, Brazil, Nigeria, United States, United Kingdom, Australia, China, South Africa, and surveys led by institutions like World Health Organization and Centers for Disease Control and Prevention. Age distribution shows peak incidence in adolescents and adults in cohort studies from Harvard School of Public Health and Johns Hopkins Bloomberg School of Public Health.

Complications and prognosis

Complications include secondary bacterial infection with organisms such as Staphylococcus aureus and Streptococcus pyogenes, cellulitis requiring hospitalization at centers like Johns Hopkins Hospital and chronic onychomycosis that may need systemic therapy as seen in studies from Mayo Clinic and Massachusetts General Hospital. Prognosis is generally favorable with appropriate antifungal therapy, though recurrence is common in longitudinal studies performed by researchers at University of California, Los Angeles and University of Barcelona.

Category:Mycoses